Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Fennec Pharmaceuticals Inc.
Updated Jul 16, 2026
Raykov Rosty has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.19M.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | FENC | FENNEC PHARMACEUTICALS INC. | S — Open-market sale | 9.6K | $10.41 | $100K |
| 2026-07-02 | FENC | FENNEC PHARMACEUTICALS INC. | M — Option exercise | 15.6K | $2.45 | $38K |
| 2026-07-02 | FENC | FENNEC PHARMACEUTICALS INC. | A — Grant or award | 2.8K | $0.00 | |
| 2026-06-02 | FENC | FENNEC PHARMACEUTICALS INC. | S — Open-market sale | 9.7K | $9.62 | $94K |
| 2026-06-02 | FENC | FENNEC PHARMACEUTICALS INC. | M — Option exercise | 15.6K | $2.45 | $38K |
| 2026-06-02 | FENC | FENNEC PHARMACEUTICALS INC. | A — Grant or award | 2.8K | $0.00 | |
| 2026-05-01 | FENC | FENNEC PHARMACEUTICALS INC. | S — Open-market sale | 10.8K | $6.47 | $70K |
| 2026-05-01 | FENC | FENNEC PHARMACEUTICALS INC. | M — Option exercise | 15.6K | $2.45 | $38K |
| 2026-05-01 | FENC | FENNEC PHARMACEUTICALS INC. | M — Option exercise | 2.8K | $0.00 | |
| 2026-04-02 | FENC | FENNEC PHARMACEUTICALS INC. | S — Open-market sale [10b5-1] | 10.9K | $6.31 | $69K |
| 2026-04-02 | FENC | FENNEC PHARMACEUTICALS INC. | M — Option exercise [10b5-1] | 15.6K | $2.45 | $38K |
| 2026-04-02 | FENC | FENNEC PHARMACEUTICALS INC. | A — Grant or award [10b5-1] | 5.2K | $0.00 | |
| 2026-03-03 | FENC | FENNEC PHARMACEUTICALS INC. | A — Grant or award [10b5-1] | 5.2K | $0.00 | |
| 2026-03-03 | FENC | FENNEC PHARMACEUTICALS INC. | S — Open-market sale [10b5-1] | 10.1K | $8.36 | $84K |
| 2026-03-03 | FENC | FENNEC PHARMACEUTICALS INC. | M — Option exercise [10b5-1] | 15.6K | $2.45 | $38K |
| 2026-02-02 | FENC | FENNEC PHARMACEUTICALS INC. | A — Grant or award | 5.2K | $0.00 | |
| 2025-12-05 | FENC | FENNEC PHARMACEUTICALS INC. | S — Open-market sale [10b5-1] | 10.0K | $7.54 | $75K |
| 2025-10-08 | FENC | FENNEC PHARMACEUTICALS INC. | M — Option exercise | 4.6K | $2.45 | $11K |
| 2025-10-06 | FENC | FENNEC PHARMACEUTICALS INC. | S — Open-market sale | 10.0K | $9.78 | $98K |
| 2025-09-30 | FENC | FENNEC PHARMACEUTICALS INC. | A — Grant or award | 5.2K | $0.00 |
Raykov Rosty is a corporate insider — currently tracked as Insider of FENNEC PHARMACEUTICALS INC. (FENC). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 18 open-market sales ($1.19M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Raykov Rosty profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.